Product Information
FLUPHENAZINE 10 MG TABLET is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $0.4309 per EA under NDC 00832600611. Its NADAC has been published 176 times since May 24, 2023.
FDA first approved this application on Oct 24, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Upsher-Smith Laboratories LLCNDC
00832600611
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FLUPHENAZINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213784FDA Approved
10/24/2022
TE Code
AB
On Market Since
11/22/2022
Pharmacological Classes
Price Statistics
The NADAC for FLUPHENAZINE 10 MG TABLET has been published 176 times since May 24, 2023, and over the history we have for it it has declined 69.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4309 per EA |
|---|---|
| All-time high | $1.6922 (Jul 12, 2023) |
| All-time low | $0.3798 (Aug 19, 2026) |
| 52-week high | $0.5435 |
| 52-week low | $0.3798 |
| Median price | $0.5180 |
| Average price | $0.5908 |
| Largest weekly change | +59.0% (Jul 17, 2024) |
| Weeks tracked | 176 |
| Tracking since | May 24, 2023 |
Generic Alternatives
The matcher finds 13 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Upsher-Smith Laboratories LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Fluphenazine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Phenothiazine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FLUPHENAZINE 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FLUPHENAZINE 10 MG TABLET, manufactured by Upsher-Smith Laboratories LLC, is $0.4309 per EA (NDC 00832600611), effective Sep 30, 2026.
How has the price of FLUPHENAZINE 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for FLUPHENAZINE 10 MG TABLET has declined 69.8%. It has been tracked across 176 weekly CMS publications since May 24, 2023.
What are the highest and lowest recorded NADAC prices for FLUPHENAZINE 10 MG TABLET?
Since May 24, 2023, the NADAC for FLUPHENAZINE 10 MG TABLET has ranged from a low of $0.3798 (Aug 19, 2026) to a high of $1.6922 (Jul 12, 2023), with a median of $0.5180 per EA.
Are there cheaper alternatives to FLUPHENAZINE 10 MG TABLET?
13 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FLUPHENAZINE 10 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures FLUPHENAZINE 10 MG TABLET?
FLUPHENAZINE 10 MG TABLET (NDC 00832600611) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.